Methylene chloride protects against cecal ligation and puncture-induced acute lung injury by modulating inflammatory mediators

International Immunopharmacology

Volumn 10, Issue 8, 2010, Pages 929-932

  Pang, Qingfeng ^a   Dou, Lidong ^a   Pan, Xiuhua ^a   Zeng, Si ^a   He, Jun ^a   Xu, Wenli ^a   Zeng, Yinming ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Carbon monoxide; Cecal ligation and perforation; Inflammation; Methylene chloride

Indexed keywords

AUTACOID; DICHLOROMETHANE; DISULFIRAM; INTERLEUKIN 10; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CECUM; COLON PERFORATION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOMODULATION; LIGATION; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MORBIDITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; CARBON MONOXIDE; CECUM; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DISULFIRAM; HUMANS; IMMUNOMODULATION; INFLAMMATION MEDIATORS; METHYLENE CHLORIDE; PEROXIDASE; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954953193     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.05.004     Document Type: Article

References (30)

1. Dernaika T.A., Keddissi J.I., Kinasewitz G.T. Update on ARDS: beyond the low tidal volume. Am J Med Sci 2009, 337:360-367.
2. Jacobson J.R. Pharmacologic therapies on the horizon for acute lung injury/acute respiratory distress syndrome. J Investig Med 2009, 57(8):870-873.
3. Phua J., Badia J.R., Adhikari N.K., Friedrich J.O., Fowler R.A., Singh J.M., et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009, 179:220-227.
4. Ryter S.W., Choi A.M. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol 2009, 41:251-260.
5. Wu L., Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005, 57:585-630.
6. Pae H.O., Lee Y.C., Chung H.T. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov 2008, 2:159-165.
7. Loboda A., Jazwa A., Grochot-Przeczek A., Rutkowski A.J., Cisowski J., Agarwal A., et al. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2008, 10:1767-1812.
8. Ryter S.W., Morse D., Choi A.M. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Mol Biol 2007, 36:175-182.
9. Ryter S.W., Choi A.M. Therapeutic applications of carbon monoxide in lung disease. Curr Opin Pharmacol 2006, 6:257-262.
10. Motterlini R., Mann B.E., Foresti R. Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005, 14:1305-1318.
11. Alcaraz M.J., Guillen M.I., Ferrandiz M.L., Megías J., Motterlini R. Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation. Curr Pharm Des 2008, 14:465-472.
12. Martins P.N., Reutzel-Selke A., Jurisch A., Denecke C., Attrot K., Pascher A., et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 2006, 82:938-944.
13. Kim S.K., Kim Y.C. Effect of a single administration of benzene, toluene or m-xylene on carboxyhaemoglobin elevation and metabolism of dichloromethane in rats. J Appl Toxicol 1996, 16:437-444.
14. Singleton K.D., Wischmeyer P.E. Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and Interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res 2003, 35:486-491.
15. Kirkby K.A., Adin C.A. Products of heme oxygenase and their potential therapeutic applications. Am J physiol Renal Physiol 2006, 290:F563-F571.
16. Takaki S., Takeyama N., Kajita Y., Yabuki T., Noguchi H., Miki Y., et al. Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock. Intensive Care Med 2010, 36:42-48.
17. Morse D., Lin L., Choi A.M. Ryter SW.Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 2009, 47:1-12.
18. Exner M., Minar E., Wagner O., Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004, 37:1097-1104.
19. Ono K., Goto Y., Takagi S., Baba S., Tago N., Nonogi H., et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart. Atherosclerosis 2004, 173:315-319.
20. Sheu C.C., Zhai R., Wang Z., Gong M.N., Tejera P., Chen F., et al. Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acuterespiratory distress syndrome. Intensive Care Med 2009, 35:1343-1351.
21. Sorhaug S., Steinshamn S., Nilsen O.G., Waldum H.L. Chronic inhalation of carbon monoxide: effects on the respiratory and cardiovascular system at doses corresponding totobacco smoking. Toxicology 2006, 228:280-290.
22. Foresti R., Bani-Hani M.G., Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 2008, 34:649-658.
23. Dhillon S., von Burg R. Methylene chloride. J Appl Toxicol 1995, 15:329-335.
24. Kirschman J.C., Brown N.M., Coots R.H., Morgareidge K. Review of investigations of dichloromethane metabolism and subchronic oral toxicity as the basis for the design of chronic oral studies in rats and mice. Food Chem Toxicol 1986, 24:943-949.
25. Gorman D.F., Runciman W.B. Carbon monoxide poisoning. Anaesth Intensive Care 1991, 19:506-511.
26. Olson K.R. Carbon monoxide poisoning: mechanisms, presentation, and controversies in management. J Emerg Med 1984, 1:233-243.
27. Kim H.P., Ryter S.W., Choi A.M. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 2006, 46:411-449.
28. Pae H.O., Oh G.S., Choi B.M., Chae S.C., Kim Y.M., Chung K.R., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004, 172:4744-4751.
29. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000, 6:422-428.
30. Morse D., Pischke S.E., Zhou Z., Davis R.J., Flavell R.A., Loop T., et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003, 278:36993-36998.